# Effect of Genetic Polymorphism on Capecitabine-Induced Toxicity in Egyptian Cancer Patients

> **NCT06765252** · — · RECRUITING · sponsor: **Ain Shams University** · enrollment: 80 (estimated)

## Conditions studied

- Colorectal Cancer
- Breast Cancer

## Interventions

- **DRUG:** Capecitabine-based chemotherapy

## Key facts

- **NCT ID:** NCT06765252
- **Lead sponsor:** Ain Shams University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-04-01
- **Primary completion:** 2025-04
- **Final completion:** 2025-08
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2025-01-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06765252

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06765252, "Effect of Genetic Polymorphism on Capecitabine-Induced Toxicity in Egyptian Cancer Patients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06765252. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*